Liminal BioSciences Inc. Common Shares
LMNL
LMNL was delisted on the 25th of September, 2023.
12 hedge funds and large institutions have $28.1M invested in Liminal BioSciences Inc. Common Shares in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$22.2M |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$279K |
| 3 |
Morgan Stanley
New York
|
+$113K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$57.3K |
| 5 |
JP Morgan Chase
New York
|
+$14.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
1
Consonance Capital Management
New York
| $27.5M | +$22.2M | +328,731 | New |
|
|
FDCDDQ
2
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $336K | +$279K | +4,144 | New |
|
|
3
Morgan Stanley
New York
| $140K | +$113K | +1,677 | New |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $71K | +$57.3K | +849 | New |
|
|
5
JP Morgan Chase
New York
| $18K | +$14.5K | +215 | New |
|
6
UBS Group
Zurich,
Switzerland
| $10K | +$7.89K | +117 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $5K | +$4.05K | +60 | New |
|
8
Bank of Montreal
Toronto,
Ontario, Canada
| $4K | +$2.97K | +44 | New |
|
|
RE
9
RBC Europe
London,
United Kingdom
| $1.96K | +$1.55K | +23 | New |
|
10
Bank of America
Charlotte,
North Carolina
| $1K | +$742 | +11 | New |
|
|
TCM
11
Tanaka Capital Management
New York
| – | +$135 | +2 | New |
|
12
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$337 | +5 | New |
|
LMNL Hedge Fund Activity: Q4 2019 in Review
12 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q4 2019, worth a combined $28.1M.
Buyers outnumbered sellers: 12 funds opened new LMNL positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $22.2M.
- 12 institutional investors held Liminal BioSciences Inc. Common Shares (LMNL) as of Q4 2019, up from 0 in Q3 2019.
- Funds reported $28.1M of Liminal BioSciences Inc. Common Shares stock for Q4 2019.
- 12 funds opened new Liminal BioSciences Inc. Common Shares positions in Q4 2019 and 0 closed out, a net change of +12 holders.
- The largest Liminal BioSciences Inc. Common Shares buyer in Q4 2019 was Consonance Capital Management, an estimated $22.2M added.
Based on aggregated 13F filings for Q4 2019.